These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 21937231)
1. Design, synthesis and insight into the structure-activity relationship of 1,3-disubstituted indazoles as novel HIF-1 inhibitors. An H; Kim NJ; Jung JW; Jang H; Park JW; Suh YG Bioorg Med Chem Lett; 2011 Nov; 21(21):6297-300. PubMed ID: 21937231 [TBL] [Abstract][Full Text] [Related]
2. Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases. McBride CM; Renhowe PA; Heise C; Jansen JM; Lapointe G; Ma S; Piñeda R; Vora J; Wiesmann M; Shafer CM Bioorg Med Chem Lett; 2006 Jul; 16(13):3595-9. PubMed ID: 16603352 [TBL] [Abstract][Full Text] [Related]
3. Scaffold oriented synthesis. Part 4: design, synthesis and biological evaluation of novel 5-substituted indazoles as potent and selective kinase inhibitors employing heterocycle forming and multicomponent reactions. Akritopoulou-Zanze I; Wakefield BD; Gasiecki A; Kalvin D; Johnson EF; Kovar P; Djuric SW Bioorg Med Chem Lett; 2011 Mar; 21(5):1480-3. PubMed ID: 21288717 [TBL] [Abstract][Full Text] [Related]
4. Discovery of indazoles as inhibitors of Tpl2 kinase. Hu Y; Cole D; Denny RA; Anderson DR; Ipek M; Ni Y; Wang X; Thaisrivongs S; Chamberlain T; Hall JP; Liu J; Luong M; Lin LL; Telliez JB; Gopalsamy A Bioorg Med Chem Lett; 2011 Aug; 21(16):4758-61. PubMed ID: 21742493 [TBL] [Abstract][Full Text] [Related]
5. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia. Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816 [TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel furoquinoline based inhibitors of multiple targets in the PI3K/Akt-mTOR pathway. Lohar MV; Mundada R; Bhonde M; Padgaonkar A; Deore V; Yewalkar N; Bhatia D; Rathos M; Joshi K; Vishwakarma RA; Kumar S Bioorg Med Chem Lett; 2008 Jun; 18(12):3603-6. PubMed ID: 18501601 [TBL] [Abstract][Full Text] [Related]
7. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis. DeNiro M; Alsmadi O; Al-Mohanna F Exp Eye Res; 2009 Nov; 89(5):700-17. PubMed ID: 19580810 [TBL] [Abstract][Full Text] [Related]
8. Structure-based design, synthesis, and antimicrobial activity of indazole-derived SAH/MTA nucleosidase inhibitors. Li X; Chu S; Feher VA; Khalili M; Nie Z; Margosiak S; Nikulin V; Levin J; Sprankle KG; Tedder ME; Almassy R; Appelt K; Yager KM J Med Chem; 2003 Dec; 46(26):5663-73. PubMed ID: 14667220 [TBL] [Abstract][Full Text] [Related]
9. Microwave expedited synthesis of 5-aminocamptothecin analogs: Inhibitors of hypoxia inducible factor HIF-1alpha. Torregrossa J; Bubley GJ; Jones GB Bioorg Med Chem Lett; 2006 Dec; 16(23):6082-5. PubMed ID: 16971123 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and SAR of indazole and benzoisoxazole containing 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists. Zhang X; Hufnagel H; Hou C; Opas E; McKenney S; Crysler C; O'Neill J; Johnson D; Sui Z Bioorg Med Chem Lett; 2011 Oct; 21(20):6042-8. PubMed ID: 21917454 [TBL] [Abstract][Full Text] [Related]
11. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells. Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464 [TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of Rho kinase inhibitors (II). Iwakubo M; Takami A; Okada Y; Kawata T; Tagami Y; Ohashi H; Sato M; Sugiyama T; Fukushima K; Iijima H Bioorg Med Chem; 2007 Jan; 15(1):350-64. PubMed ID: 17046269 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of new α aminophosphonate system bearing Indazole moiety and their biological activity. Ali Na; Zakir S; Patel M; Farooqui M Eur J Med Chem; 2012 Apr; 50():39-43. PubMed ID: 22341789 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of 6-anilinoindazoles as selective inhibitors of c-Jun N-terminal kinase-3. Swahn BM; Huerta F; Kallin E; Malmström J; Weigelt T; Viklund J; Womack P; Xue Y; Ohberg L Bioorg Med Chem Lett; 2005 Nov; 15(22):5095-9. PubMed ID: 16140012 [TBL] [Abstract][Full Text] [Related]
15. New hypotheses for the binding mode of 4- and 7-substituted indazoles in the active site of neuronal nitric oxide synthase. Lohou E; Sopkova-de Oliveira Santos J; Schumann-Bard P; Boulouard M; Stiebing S; Rault S; Collot V Bioorg Med Chem; 2012 Sep; 20(17):5296-304. PubMed ID: 22831803 [TBL] [Abstract][Full Text] [Related]
16. HIF-1α inhibitors: synthesis and biological evaluation of novel moracin O and P analogues. Xia Y; Jin Y; Kaur N; Choi Y; Lee K Eur J Med Chem; 2011 Jun; 46(6):2386-96. PubMed ID: 21481991 [TBL] [Abstract][Full Text] [Related]
17. Discovery of novel hydroxy-thiazoles as HIF-alpha prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluation. Tegley CM; Viswanadhan VN; Biswas K; Frohn MJ; Peterkin TA; Chang C; Bürli RW; Dao JH; Veith H; Rogers N; Yoder SC; Biddlecome G; Tagari P; Allen JR; Hungate RW Bioorg Med Chem Lett; 2008 Jul; 18(14):3925-8. PubMed ID: 18579373 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of (aryloxyacetylamino)-isonicotinic/nicotinic acid analogues as potent hypoxia-inducible factor (HIF)-1alpha inhibitors. Boovanahalli SK; Jin X; Jin Y; Kim JH; Dat NT; Hong YS; Lee JH; Jung SH; Lee K; Lee JJ Bioorg Med Chem Lett; 2007 Nov; 17(22):6305-10. PubMed ID: 17884495 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of hypoxia-inducible factor-1 alpha by cobalt chloride prevents hearing loss in noise-exposed mice. Chung JW; Shin JE; Han KW; Ahn JH; Kim YJ; Park JW; So HS Environ Toxicol Pharmacol; 2011 Jan; 31(1):153-9. PubMed ID: 21787680 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, antimicrobial activity and QSAR studies of new 2,3-disubstituted-3,3a,4,5,6,7-hexahydro-2H-indazoles. Minu M; Thangadurai A; Wakode SR; Agrawal SS; Narasimhan B Bioorg Med Chem Lett; 2009 Jun; 19(11):2960-4. PubMed ID: 19410452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]